Suppliers / Altaire Pharmaceuticals

Altaire Pharmaceuticals

United States 43 employees Updated 9 July 2026

Altaire Pharmaceuticals is a finished-dose manufacturer based in United States. It appears in 5 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its most recent recorded inspection, by US FDA, closed on 11 February 2022 as OAI.

0
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
5
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 11 February 2022 OAI US FDA
  • 19 April 2019 OAI US FDA
  • 9 March 2017 VAI US FDA
  • 15 December 2015 VAI US FDA
  • 13 April 2015 VAI US FDA
  • 29 July 2014 VAI US FDA
  • 8 August 2013 VAI US FDA
  • 7 June 2012 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Aquebogue, United States 1000119582

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 5 None

Questions about Altaire Pharmaceuticals

Does Altaire Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Altaire Pharmaceuticals. It does have 5 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Is Altaire Pharmaceuticals FDA-registered?
One site operated by Altaire Pharmaceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Altaire Pharmaceuticals's last inspection go?
The most recent inspection on record closed on 11 February 2022 as OAI (Official Action Indicated, the worst classification: objectionable conditions were found and regulatory action was warranted). 8 inspections are on file, of which 2 closed as OAI.
Where does Altaire Pharmaceuticals manufacture?
1 registered site is on record, in United States (Aquebogue). Every site is listed on this page with the register it came from.
Where does Altaire Pharmaceuticals file?
Filings are on record with US FDA, 5 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Altaire Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was OAI, on 11 February 2022.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability